Status: Recruiting
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
The purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IMP) administration.
Participants needed: 350
Trial details
Phase: Phase 3Age: 12+Biological sex: AllType: InterventionalSponsor: UCB Biopharma SRLUpdated: Jul 1, 2026Locations: 183
Eligibility criteria
Participant must be ≥12 years of age at the Baseline/Randomization Visit [+10]
Participant has a current history of alcohol or drug use disorder, as defined in... [+24]